MATERNAL EXPOSURE TIMING UNSPECIFIED

This adverse event was reported 3760 times

These drugs are most commonly taken by patients reporting MATERNAL EXPOSURE TIMING UNSPECIFIED:

# Drug Count
0 ACETAMINOPHEN 570
1 RITUXIMAB 557
2 SERTRALINE HYDROCHLORIDE 548
3 ADALIMUMAB 470
4 TOCILIZUMAB 465
5 FOLIC ACID 458
6 DICLOFENAC SODIUM 455
7 DICLOFENAC 447
8 METHOTREXATE SODIUM 447
9 PREDNISONE 437
See all common drugs associated with MATERNAL EXPOSURE TIMING UNSPECIFIED

MATERNAL EXPOSURE TIMING UNSPECIFIED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TRIPROLIDINE HYDROCHLORIDE 17 0.0872
1 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 14 0.0456
2 HYDROCORTISONE BUTYRATE 79 0.0400
3 CAFFEINE CITRATE 91 0.0390
4 NEOMYCIN OINTMENT 74 0.0302
5 RITUXIMAB AND HYALURONIDASE 13 0.0287
6 DICLOFENAC POTASSIUM TABLETS 244 0.0281
7 GOLIMUMAB 337 0.0268
8 HYDROCORTISONE SODIUM SUCCINATE 96 0.0240
9 DICLOFENAC POTASSIUM 244 0.0221
See all drugs enriched for association with MATERNAL EXPOSURE TIMING UNSPECIFIED

MATERNAL EXPOSURE TIMING UNSPECIFIED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Endoglycosidase [EPC] 82 0.0443
1 Interleukin-5 Antagonist [EPC] 24 0.0349
2 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 153 0.0175
3 Interleukin-17A Antagonist [EPC] 416 0.0112
4 Provitamin D2 Compound [EPC] 240 0.0081
5 CD19-directed Cytolytic Antibody [EPC] 4 0.0047
6 Survival of Motor Neuron 2 Splicing Modifier [EPC] 18 0.0043
7 Aminosalicylate [EPC] 431 0.0043
8 Methylxanthine [EPC] 239 0.0041
9 Oxytocic [EPC] 12 0.0039
See all drug classes enriched for association with MATERNAL EXPOSURE TIMING UNSPECIFIED